Approval · Notice of Compliance 1023 · 2003
OMNISCAN: Notice of Compliance 1023
Issued March 4, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1023
- Date
- March 4, 2003
- Company
- Amersham Health Inc.Mississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Contrast enhancement agent for magnetic resonance imaging (mri)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OMNISCAN | 02172771 | Marketed |
Medicinal ingredients
- GADODIAMIDE 287 MG per ML